메뉴 건너뛰기




Volumn 189, Issue 4, 2008, Pages 223-227

Why we need a national registry in interventional cardiology

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; FIBRINOGEN RECEPTOR ANTAGONIST; FIBRINOLYTIC AGENT;

EID: 51349089588     PISSN: 0025729X     EISSN: None     Source Type: Journal    
DOI: 10.5694/j.1326-5377.2008.tb01989.x     Document Type: Article
Times cited : (14)

References (50)
  • 1
    • 33947192117 scopus 로고    scopus 로고
    • Drug-eluting stents - a note of caution
    • Harper RW. Drug-eluting stents - a note of caution. Med J Aust 2007; 186: 253-255.
    • (2007) Med J Aust , vol.186 , pp. 253-255
    • Harper, R.W.1
  • 2
    • 0141613164 scopus 로고    scopus 로고
    • Primary angioplasty versus intravenous thrombolysis for acute myocardial infarction
    • CD001560
    • Cucherat M, Bonnefoy E, Tremeau G. Primary angioplasty versus intravenous thrombolysis for acute myocardial infarction. Cochrane Database Syst Rev 2003; (3): CD001560.
    • (2003) Cochrane Database Syst Rev , Issue.3
    • Cucherat, M.1    Bonnefoy, E.2    Tremeau, G.3
  • 3
    • 0033606918 scopus 로고    scopus 로고
    • SHOCK Investigators. Early revascularization in acute myocardial infarction complicated by cardiogenic shock
    • Hochman JS, Sleeper LA, Webb JG, et al; SHOCK Investigators. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. N Engl J Med 1999; 341: 625-634.
    • (1999) N Engl J Med , vol.341 , pp. 625-634
    • Hochman, J.S.1    Sleeper, L.A.2    Webb, J.G.3
  • 4
    • 29544444716 scopus 로고    scopus 로고
    • REACT Trial Investigators. Rescue angioplasty after failed thrombolytic therapy for acute myocardial infarction
    • Gershlick AH, Stephens-Lloyd A, Hughes S, et al; REACT Trial Investigators. Rescue angioplasty after failed thrombolytic therapy for acute myocardial infarction. N Engl J Med 2005; 353: 2758-2768.
    • (2005) N Engl J Med , vol.353 , pp. 2758-2768
    • Gershlick, A.H.1    Stephens-Lloyd, A.2    Hughes, S.3
  • 5
    • 34848833529 scopus 로고    scopus 로고
    • Assessing the influence of primary angioplasty compared with thrombolysis and its relationship to time delay: A Bayesian evidence synthesis
    • Asseburg C, Bravo Vergel Y, Palmer S, et al. Assessing the influence of primary angioplasty compared with thrombolysis and its relationship to time delay: a Bayesian evidence synthesis. Heart 2007; 93: 1244-1250.
    • (2007) Heart , vol.93 , pp. 1244-1250
    • Asseburg, C.1    Bravo Vergel, Y.2    Palmer, S.3
  • 6
    • 33845453212 scopus 로고    scopus 로고
    • Occluded Artery Trial Investigators. Coronary intervention for persistent occlusion after myocardial infarction
    • Hochman JS, Lamas GA, Buller CE, et al; Occluded Artery Trial Investigators. Coronary intervention for persistent occlusion after myocardial infarction. N Engl J Med 2006; 355: 2395-2407.
    • (2006) N Engl J Med , vol.355 , pp. 2395-2407
    • Hochman, J.S.1    Lamas, G.A.2    Buller, C.E.3
  • 7
    • 33750095914 scopus 로고    scopus 로고
    • Early invasive versus conservative strategies for unstable angina & non-ST-elevation myocardial infarction in the stent era
    • CD004815
    • Hoenig MR, Doust JA, Aroney CN, Scott IA. Early invasive versus conservative strategies for unstable angina & non-ST-elevation myocardial infarction in the stent era. Cochrane Database Syst Rev 2006; (3): CD004815.
    • (2006) Cochrane Database Syst Rev , Issue.3
    • Hoenig, M.R.1    Doust, J.A.2    Aroney, C.N.3    Scott, I.A.4
  • 8
    • 20444504004 scopus 로고    scopus 로고
    • Percutaneous coronary interventions vs conservative therapy in nonacute coronary disease. A meta-analysis
    • Katritsis DG, Ioannidis JP. Percutaneous coronary interventions vs conservative therapy in nonacute coronary disease. A meta-analysis. Circulation 2005; 111: 2906-2912.
    • (2005) Circulation , vol.111 , pp. 2906-2912
    • Katritsis, D.G.1    Ioannidis, J.P.2
  • 9
    • 34247113737 scopus 로고    scopus 로고
    • COURAGE Trial Research Group. Optimal medical therapy with or without PCI for stable coronary disease
    • Boden WE, O'Rourke RA, Teo KK, et al; COURAGE Trial Research Group. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med 2007; 356: 1503-1516.
    • (2007) N Engl J Med , vol.356 , pp. 1503-1516
    • Boden, W.E.1    O'Rourke, R.A.2    Teo, K.K.3
  • 10
    • 38449101262 scopus 로고    scopus 로고
    • Systematic review: The comparative effectiveness of percutaneous coronary interventions and coronary artery bypass graft surgery
    • Bravata DM, Gienger AL, McDonald KM, et al. Systematic review: the comparative effectiveness of percutaneous coronary interventions and coronary artery bypass graft surgery. Ann Intern Med 2007; 147: 703-716.
    • (2007) Ann Intern Med , vol.147 , pp. 703-716
    • Bravata, D.M.1    Gienger, A.L.2    McDonald, K.M.3
  • 11
    • 33947606182 scopus 로고    scopus 로고
    • Five-year follow-up of the Medicine, Angioplasty, or Surgery Study (MASS II). A randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease
    • Hueb W, Lopes NH, Gersh BJ, et al. Five-year follow-up of the Medicine, Angioplasty, or Surgery Study (MASS II). A randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease. Circulation 2007; 115: 1082-1089.
    • (2007) Circulation , vol.115 , pp. 1082-1089
    • Hueb, W.1    Lopes, N.H.2    Gersh, B.J.3
  • 12
    • 34147176083 scopus 로고    scopus 로고
    • Stent thrombosis late after implantation of first-generation drug-eluting stents. A cause for concern
    • Camenzind E, Steg PG, Wijns W. Stent thrombosis late after implantation of first-generation drug-eluting stents. A cause for concern. Circulation 2007; 115: 1440-1455.
    • (2007) Circulation , vol.115 , pp. 1440-1455
    • Camenzind, E.1    Steg, P.G.2    Wijns, W.3
  • 13
    • 4143096183 scopus 로고    scopus 로고
    • A hierarchical Bayesian meta-analysis of randomised clinical trials of drug-eluting stents
    • Babapulle MN, Joseph L, Bélisle P, et al. A hierarchical Bayesian meta-analysis of randomised clinical trials of drug-eluting stents. Lancet 2004; 364: 583-591.
    • (2004) Lancet , vol.364 , pp. 583-591
    • Babapulle, M.N.1    Joseph, L.2    Bélisle, P.3
  • 14
    • 17844373254 scopus 로고    scopus 로고
    • Incidence, predictors, and outcome of thrombosis after successful implementation of drug-eluting stents
    • Iakovou I, Schmidt T, Bonizzoni E, et al. Incidence, predictors, and outcome of thrombosis after successful implementation of drug-eluting stents. JAMA 2005; 293: 2126-2130.
    • (2005) JAMA , vol.293 , pp. 2126-2130
    • Iakovou, I.1    Schmidt, T.2    Bonizzoni, E.3
  • 15
    • 33845319222 scopus 로고    scopus 로고
    • BASKET-LATE Investigators. Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: An observational study of drug-eluting versus bare-metal stents
    • Pfisterer M, Brunner-La Rocca HP, Buser PT, et al; BASKET-LATE Investigators. Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents. J Am Coll Cardiol 2006; 48: 2584-2591.
    • (2006) J Am Coll Cardiol , vol.48 , pp. 2584-2591
    • Pfisterer, M.1    Brunner-La Rocca, H.P.2    Buser, P.T.3
  • 16
    • 33847705701 scopus 로고    scopus 로고
    • Stent thrombosis in randomized clinical trials of drug-eluting stents
    • Mauri L, Hsieh WH, Massaro JM, et al. Stent thrombosis in randomized clinical trials of drug-eluting stents. N Engl J Med 2007; 356: 1020-1029.
    • (2007) N Engl J Med , vol.356 , pp. 1020-1029
    • Mauri, L.1    Hsieh, W.H.2    Massaro, J.M.3
  • 17
    • 34548542073 scopus 로고    scopus 로고
    • Outcomes associated with drug-eluting bare-metal stents: A collaborative network meta-analysis
    • Stettler C, Wandel S, Allemann S, et al. Outcomes associated with drug-eluting bare-metal stents: a collaborative network meta-analysis. Lancet 2007; 370: 937-948.
    • (2007) Lancet , vol.370 , pp. 937-948
    • Stettler, C.1    Wandel, S.2    Allemann, S.3
  • 18
    • 33846125284 scopus 로고    scopus 로고
    • Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation
    • Eisenstein EL, Anstrom KJ, Kong DF, et al. Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation. JAMA 2007; 297: 159-168.
    • (2007) JAMA , vol.297 , pp. 159-168
    • Eisenstein, E.L.1    Anstrom, K.J.2    Kong, D.F.3
  • 19
    • 33745960402 scopus 로고    scopus 로고
    • Prevalence, predictors, and outcomes of premature discontinuation of thienopyridine therapy after drug-eluting stent placement: Results from the PREMIER registry
    • Spertus JA, Kettelkamp R, Vance C, et al. Prevalence, predictors, and outcomes of premature discontinuation of thienopyridine therapy after drug-eluting stent placement: results from the PREMIER registry. Circulation 2006; 113: 2803-2809.
    • (2006) Circulation , vol.113 , pp. 2803-2809
    • Spertus, J.A.1    Kettelkamp, R.2    Vance, C.3
  • 20
    • 33745303804 scopus 로고    scopus 로고
    • Narrative review: Drug-eluting stents for the management of restenosis: a critical appraisal of the evidence
    • Tung R, Kaul S, Diamond GA, Shah PK. Narrative review: drug-eluting stents for the management of restenosis: a critical appraisal of the evidence. Ann Intern Med 2006; 144: 913-919.
    • (2006) Ann Intern Med , vol.144 , pp. 913-919
    • Tung, R.1    Kaul, S.2    Diamond, G.A.3    Shah, P.K.4
  • 21
    • 0037120818 scopus 로고    scopus 로고
    • TACTICS-TIMI 18 Investigators. Treat Angina with aggrastat and determine Cost of Therapy with an Invasive or Conservative Strategy - Thrombolysis In Myocardial Infarction. Cost and cost-effectiveness of an early invasive vs conservative strategy for the treatment of unstable angina and non-ST-segment elevation myocardial infarction
    • Mahoney EM, Jurkovitz CT, Chu H, et al; TACTICS-TIMI 18 Investigators. Treat Angina with aggrastat and determine Cost of Therapy with an Invasive or Conservative Strategy - Thrombolysis In Myocardial Infarction. Cost and cost-effectiveness of an early invasive vs conservative strategy for the treatment of unstable angina and non-ST-segment elevation myocardial infarction. JAMA 2002; 288: 1851-1858.
    • (2002) JAMA , vol.288 , pp. 1851-1858
    • Mahoney, E.M.1    Jurkovitz, C.T.2    Chu, H.3
  • 22
    • 33947718150 scopus 로고    scopus 로고
    • Cost effectiveness of clinically appropriate decisions on alternative treatments for angina pectoris: Prospective observational study
    • Griffin SC, Barber JA, Manca A, et al. Cost effectiveness of clinically appropriate decisions on alternative treatments for angina pectoris: prospective observational study. BMJ 2007; 334: 624-631.
    • (2007) BMJ , vol.334 , pp. 624-631
    • Griffin, S.C.1    Barber, J.A.2    Manca, A.3
  • 23
    • 27944441327 scopus 로고    scopus 로고
    • A systematic review and economic analysis of drug-eluting coronary stents available in Australia
    • Lord SJ, Howard K, Allen F, et al. A systematic review and economic analysis of drug-eluting coronary stents available in Australia. Med J Aust 2005; 183: 464-471.
    • (2005) Med J Aust , vol.183 , pp. 464-471
    • Lord, S.J.1    Howard, K.2    Allen, F.3
  • 24
    • 3543064732 scopus 로고    scopus 로고
    • Cost-effectiveness of sirolimus-eluting stents for treatment of complex coronary stenoses: Results from the Sirolimus-Eluting Balloon Expandable Stent in the Treatment of Patients with De Novo Native Coronary Artery Lesions (SIRIUS) trial
    • Cohen DJ, Bakhai A, Shi C, et al. Cost-effectiveness of sirolimus-eluting stents for treatment of complex coronary stenoses: results from the Sirolimus-Eluting Balloon Expandable Stent in the Treatment of Patients with De Novo Native Coronary Artery Lesions (SIRIUS) trial. Circulation 2004; 110: 508-514.
    • (2004) Circulation , vol.110 , pp. 508-514
    • Cohen, D.J.1    Bakhai, A.2    Shi, C.3
  • 25
    • 24644523719 scopus 로고    scopus 로고
    • Incremental cost-effectiveness of drug-eluting stents compared with a third-generation bare-metal stent in a real-world setting: Randomised Basal Stent Kosten Effektivitäts Trial (BASKET)
    • Kaiser C, Brunner-La Rocca HP, Buser PT, et al. Incremental cost-effectiveness of drug-eluting stents compared with a third-generation bare-metal stent in a real-world setting: randomised Basal Stent Kosten Effektivitäts Trial (BASKET). Lancet 2005; 366: 921-929.
    • (2005) Lancet , vol.366 , pp. 921-929
    • Kaiser, C.1    Brunner-La Rocca, H.P.2    Buser, P.T.3
  • 26
    • 33750494332 scopus 로고    scopus 로고
    • New York State Angioplasty Registry. Comparison of outcomes of percutaneous coronary interventions in patients of three age groups (<60, 60 to 80, and >80 years) from the New York State Angioplasty Registry
    • Feldman DN, Gade CL, Slotwiner AJ, et al; New York State Angioplasty Registry. Comparison of outcomes of percutaneous coronary interventions in patients of three age groups (<60, 60 to 80, and >80 years) from the New York State Angioplasty Registry. Am J Cardiol 2006; 98: 1334-1339.
    • (2006) Am J Cardiol , vol.98 , pp. 1334-1339
    • Feldman, D.N.1    Gade, C.L.2    Slotwiner, A.J.3
  • 27
    • 13844275557 scopus 로고    scopus 로고
    • Times to treatment in transfer patients undergoing primary percutaneous coronary intervention in the United States: National Registry of Myocardial Infarction (NRMI)-3/4 analysis
    • Nallamothu BK, Bates ER, Herrin J, et al. Times to treatment in transfer patients undergoing primary percutaneous coronary intervention in the United States: National Registry of Myocardial Infarction (NRMI)-3/4 analysis. Circulation 2005; 111: 761-767.
    • (2005) Circulation , vol.111 , pp. 761-767
    • Nallamothu, B.K.1    Bates, E.R.2    Herrin, J.3
  • 28
    • 33846582933 scopus 로고    scopus 로고
    • GRACE investigators. Intervention in acute coronary syndromes: Do patients undergo intervention on the basis of their risk characteristics? The Global Registry of Acute Coronary Events (GRACE)
    • Fox KA, Anderson FA Jr, Dabbous OH, et al; GRACE investigators. Intervention in acute coronary syndromes: do patients undergo intervention on the basis of their risk characteristics? The Global Registry of Acute Coronary Events (GRACE). Heart 2007; 93: 177-182.
    • (2007) Heart , vol.93 , pp. 177-182
    • Fox, K.A.1    Anderson Jr, F.A.2    Dabbous, O.H.3
  • 29
    • 34548009153 scopus 로고    scopus 로고
    • Cardiologists' use of percutaneous coronary interventions for stable coronary disease
    • Lin GA, Dudley A, Redberg RF. Cardiologists' use of percutaneous coronary interventions for stable coronary disease. Arch Intern Med 2007; 167: 1604-1609.
    • (2007) Arch Intern Med , vol.167 , pp. 1604-1609
    • Lin, G.A.1    Dudley, A.2    Redberg, R.F.3
  • 30
    • 33847064642 scopus 로고    scopus 로고
    • In unstable angina or non-ST-segment acute coronary syndromes, should patients with multivessel coronary disease undergo multivessel or culprit-only stenting?
    • Shishehbor MH, Lauer MS, Singh IM, et al. In unstable angina or non-ST-segment acute coronary syndromes, should patients with multivessel coronary disease undergo multivessel or culprit-only stenting? J Am Coll Cardiol 2007; 49: 849-854.
    • (2007) J Am Coll Cardiol , vol.49 , pp. 849-854
    • Shishehbor, M.H.1    Lauer, M.S.2    Singh, I.M.3
  • 31
    • 14244251065 scopus 로고    scopus 로고
    • Contemporary management of acute coronary syndromes: Does the practice match the evidence? The Global Registry of Acute Coronary Events (GRACE)
    • Carruthers KF, Dabbous OH, Flather MD, et al. Contemporary management of acute coronary syndromes: does the practice match the evidence? The Global Registry of Acute Coronary Events (GRACE). Heart 2005; 91: 290-298.
    • (2005) Heart , vol.91 , pp. 290-298
    • Carruthers, K.F.1    Dabbous, O.H.2    Flather, M.D.3
  • 32
    • 51349129884 scopus 로고    scopus 로고
    • Center for Devices and Radiological Health
    • 4 Jan, accessed Sep 2007
    • United States Food and Drug Administration; Center for Devices and Radiological Health. Update to FDA statement on coronary drug-eluting stents. 2007; 4 Jan. http://www.fda.gov/cdrh/news/010407.html (accessed Sep 2007).
    • (2007) Update to FDA statement on coronary drug-eluting stents
  • 33
    • 34548693252 scopus 로고    scopus 로고
    • Drug-eluting stent update 2007. Part III. Technique and unapproved/unsettled indications (left main, bifurcations, chronic total occlusions, small vessels and long lesions, saphenous vein grafts, acute myocardial infarctions, and multivessel disease)
    • Colombo A, Chieffo A. Drug-eluting stent update 2007. Part III. Technique and unapproved/unsettled indications (left main, bifurcations, chronic total occlusions, small vessels and long lesions, saphenous vein grafts, acute myocardial infarctions, and multivessel disease). Circulation 2007; 116: 1424-1432.
    • (2007) Circulation , vol.116 , pp. 1424-1432
    • Colombo, A.1    Chieffo, A.2
  • 34
    • 34248329889 scopus 로고    scopus 로고
    • Outcomes and complications associated with off-label and untested use of drug-eluting stents
    • Beohar N, Davidson CJ, Kip KE, et al. Outcomes and complications associated with off-label and untested use of drug-eluting stents. JAMA 2007; 297: 1992-2000.
    • (2007) JAMA , vol.297 , pp. 1992-2000
    • Beohar, N.1    Davidson, C.J.2    Kip, K.E.3
  • 35
    • 34248376428 scopus 로고    scopus 로고
    • EVENT Registry Investigators. Clinical outcomes and stent thrombosis following off-label use of drug-eluting stents
    • Win HK, Caldera AE, Maresh K, et al; EVENT Registry Investigators. Clinical outcomes and stent thrombosis following off-label use of drug-eluting stents. JAMA 2007; 297: 2001-2009.
    • (2007) JAMA , vol.297 , pp. 2001-2009
    • Win, H.K.1    Caldera, A.E.2    Maresh, K.3
  • 36
    • 38549120402 scopus 로고    scopus 로고
    • A comparison of bare-metal and drug-eluting stents for off-label indications
    • Marroquin OC, Seizer F, Mulukutla SR, et al. A comparison of bare-metal and drug-eluting stents for off-label indications. N Engl J Med 2008; 358: 342-352.
    • (2008) N Engl J Med , vol.358 , pp. 342-352
    • Marroquin, O.C.1    Seizer, F.2    Mulukutla, S.R.3
  • 37
    • 33847762819 scopus 로고    scopus 로고
    • SCAAR Study Group. Long-term outcomes with drug-eluting versus bare-metal stents in Sweden
    • Lagerqvist B, James SK, Stenestrand U, et al; SCAAR Study Group. Long-term outcomes with drug-eluting versus bare-metal stents in Sweden. N Engl J Med 2007; 356: 1009-1019.
    • (2007) N Engl J Med , vol.356 , pp. 1009-1019
    • Lagerqvist, B.1    James, S.K.2    Stenestrand, U.3
  • 38
    • 51349087477 scopus 로고    scopus 로고
    • Wood S. New Swedish registry results show no overall increased deaths with DES out to four years. theheart.org 2007; 2 Sep. http://www.theheart.org/article/808471.do (accessed Jan 2008).
    • Wood S. New Swedish registry results show no overall increased deaths with DES out to four years. theheart.org 2007; 2 Sep. http://www.theheart.org/article/808471.do (accessed Jan 2008).
  • 39
    • 33847167065 scopus 로고    scopus 로고
    • Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: Data from a large two-institutional cohort study
    • Daemen J, Wenaweser P, Tsuchida K, et al. Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study. Lancet 2007; 369: 667-678.
    • (2007) Lancet , vol.369 , pp. 667-678
    • Daemen, J.1    Wenaweser, P.2    Tsuchida, K.3
  • 40
    • 34948904387 scopus 로고    scopus 로고
    • Effectiveness and safety of drug-eluting stents in Ontario
    • Tu JV, Bowen J, Chiu M, et al. Effectiveness and safety of drug-eluting stents in Ontario. N Engl J Med 2007; 357: 1393-1402.
    • (2007) N Engl J Med , vol.357 , pp. 1393-1402
    • Tu, J.V.1    Bowen, J.2    Chiu, M.3
  • 41
    • 36048973194 scopus 로고    scopus 로고
    • Unrestricted use of drug-eluting stents compared with bare-metal stents in routine clinical practice
    • Abbott JD, Voss MR, Nakaruma M, et al. Unrestricted use of drug-eluting stents compared with bare-metal stents in routine clinical practice. J Am Coll Cardiol 2007; 50: 2029-2036.
    • (2007) J Am Coll Cardiol , vol.50 , pp. 2029-2036
    • Abbott, J.D.1    Voss, M.R.2    Nakaruma, M.3
  • 42
    • 42449100082 scopus 로고    scopus 로고
    • Studies of drug-eluting stents. To each his own?
    • Mauri L, Normand ST. Studies of drug-eluting stents. To each his own? Circulation 2008; 117: 2047-2050.
    • (2008) Circulation , vol.117 , pp. 2047-2050
    • Mauri, L.1    Normand, S.T.2
  • 43
    • 45849144423 scopus 로고    scopus 로고
    • Outcomes following coronary stenting in the era of bare-metal vs the era of drug-eluting stents
    • Malenka DJ, Kaplan AV, Lucas FL, et al. Outcomes following coronary stenting in the era of bare-metal vs the era of drug-eluting stents. JAMA 2008; 299: 2868-2876.
    • (2008) JAMA , vol.299 , pp. 2868-2876
    • Malenka, D.J.1    Kaplan, A.V.2    Lucas, F.L.3
  • 44
    • 0142041382 scopus 로고    scopus 로고
    • Predictors of major bleeding in acute coronary syndromes: The Global Registry of Acute Coronary Events (GRACE)
    • Moscucci M, Fox KA, Cannon CP, et al. Predictors of major bleeding in acute coronary syndromes: the Global Registry of Acute Coronary Events (GRACE). Eur Heart J 2003; 24: 1815-1823.
    • (2003) Eur Heart J , vol.24 , pp. 1815-1823
    • Moscucci, M.1    Fox, K.A.2    Cannon, C.P.3
  • 45
    • 33745058140 scopus 로고    scopus 로고
    • Combination therapy with aspirin, clopidogrel and warfarin following coronary stenting is associated with a significant risk of bleeding
    • Khurram Z, Chou E, Minutello R, et al. Combination therapy with aspirin, clopidogrel and warfarin following coronary stenting is associated with a significant risk of bleeding. J Invasive Cardiol 2006; 18: 162-164.
    • (2006) J Invasive Cardiol , vol.18 , pp. 162-164
    • Khurram, Z.1    Chou, E.2    Minutello, R.3
  • 46
    • 51349099147 scopus 로고    scopus 로고
    • Australian Institute of Health and Welfare. Australia's health 2008. Canberra: AIHW, 2008. (AIHW Cat. No. AUS 99.)
    • Australian Institute of Health and Welfare. Australia's health 2008. Canberra: AIHW, 2008. (AIHW Cat. No. AUS 99.)
  • 47
    • 51349110309 scopus 로고    scopus 로고
    • Davies J, Senes S. Coronary angioplasty in Australia 1999. Canberra: Australian Institute of Health and Welfare; National Heart Foundation of Australia, 2002. (AIHW Cat. No. CVD 19; Cardiovascular Disease Series No. 19.)
    • Davies J, Senes S. Coronary angioplasty in Australia 1999. Canberra: Australian Institute of Health and Welfare; National Heart Foundation of Australia, 2002. (AIHW Cat. No. CVD 19; Cardiovascular Disease Series No. 19.)
  • 48
    • 34848924471 scopus 로고    scopus 로고
    • Current management of acute coronary syndromes in Australia: Observations from the acute coronary syndromes prospective audit
    • Chew DP, Amerena J, Coverdale S, et al. Current management of acute coronary syndromes in Australia: observations from the acute coronary syndromes prospective audit. Intern Med J 2007; 37: 741-748.
    • (2007) Intern Med J , vol.37 , pp. 741-748
    • Chew, D.P.1    Amerena, J.2    Coverdale, S.3
  • 49
    • 33749592770 scopus 로고    scopus 로고
    • Use of drug-eluting stents in Victorian public hospitals
    • Yan BP, Ajani AE, Duffy SJ, et al. Use of drug-eluting stents in Victorian public hospitals. Med J Aust 2006; 185: 363-367.
    • (2006) Med J Aust , vol.185 , pp. 363-367
    • Yan, B.P.1    Ajani, A.E.2    Duffy, S.J.3
  • 50
    • 0034988582 scopus 로고    scopus 로고
    • Why Australia needs a Cardiac Procedures Database
    • Tonkin AM. Why Australia needs a Cardiac Procedures Database. Heart Lung Circ 2001; 10(1 Suppl): S22-S25.
    • (2001) Heart Lung Circ , vol.10 , Issue.1 SUPPL.
    • Tonkin, A.M.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.